Experience

Panacea Biotec

• India
• Pharmaceutical Manufacturing
• 100 - 200 Employee

• Group Leader

  • Jul 2021 - Present

  Team building of 4-5 Scientists with passion and innovation to achieve organization Goals in the area of Injectables, Complex Injectables i.e. nanoparticles, liposones, Inhalation products and NDDS projects in OSD domain. Responsible for innovative products identification, POC establishment, R&D facilities set up, Loan license facilities identification, Bioequivelence facilities identification, third party facilities identification, Scale up batches, technology transfer to the plant and support to plant for execution of Exhibit batches.



Glenmark Pharmaceuticals

• India
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Research Scientist

  • Jul 2020 - Jun 2021

  Leading projects of Complex Injectable, Iron Products, Inhalation Suspension, Opthalmic Solution. I am involve in Project initiation to commercialization for US and Europe Market.

• Senior Research Officer

  • Feb 2017 - Jun 2020

  Liquid Injectables, Nanoparticle based formulations, Suspension, Lyophilization for US and Europe products



Richter Themis Medicare (I) Pvt Ltd

• Pharmaceutical Manufacturing
• 100 - 200 Employee

• Executive-R&D

  • Apr 2016 - Feb 2017

  Formulation & Development of Liquid Injectables for Europe and US market based on 505 (b2) conceptFormulation & Development of Oral Solids dosage forms for Domestic as well as semi regulated marketDoccuments preparation like MFC, BMR, PDR, BOM, SOP, etc. Formulation & Development of Liquid Injectables for Europe and US market based on 505 (b2) conceptFormulation & Development of Oral Solids dosage forms for Domestic as well as semi regulated marketDoccuments preparation like MFC, BMR, PDR, BOM, SOP, etc.



Cadila Pharmaceuticals Limited

• India
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Executive

  • Aug 2014 - Mar 2016

  Formulation develoment of NDDS formulations, Liposomes, Vaccines, Topical, Injectable, Tablets, Capsules and lyophilized formulations.Project Identification for physeability of formulation and development,BOM for Cost calculations, timeline preparationsSOP, MFC, MMD and PDR writing, Stability studies designing.Scale up batches Formulation develoment of NDDS formulations, Liposomes, Vaccines, Topical, Injectable, Tablets, Capsules and lyophilized formulations.Project Identification for physeability of formulation and development,BOM for Cost calculations, timeline preparationsSOP, MFC, MMD and PDR writing, Stability studies designing.Scale up batches



Central Drug Research Institute, Lucknow

• Pharmaceutical Manufacturing
• 300 - 400 Employee

• CSIR-SRF

  • Jun 2011 - Aug 2014

  Designing of projects, experiments and timely executions.Formulation development of Lipo-polymerosome, liposome, micelle, SLN, NLC, Lipid conjugate, nano-emulsion, nano-suspension, nanocrystal and nanoparticles.Synthesis and characterization of copolymers from biodegradable and biocompatible polymers and lipids.Particle size reduction by microfluidizer, sonicator, extrusion.Particle size characterization by Nano-ZS, Meta Sizer, AFM, FESEM, HRTEM.Stability studies.Cost reduction and process improvement studiesPharmacokinetic and biodistribution studies in various animal models.Toxicity, immunogenicity and efficacy studies in various animal models.Targeting efficacy studies of molecular ligand on in vitro and in vivo models. Writting of manuscripts, reports, review articles, etc. Wrote several research projects to get funding from ICMR, DST, DBT and UGC.Presentation of research data in various international congresses.

• CSIR-JRF

  • Mar 2010 - Jun 2011

  Job responsibilities:1. Designed Novel drug delivery systems basically injectables for immediate release, modified release and sustained release of drugs.2. Formulation development of nanoparticle formulation for blood brain barrier targeting for oncological diseases.3. Design of experiments involving process development, cost reduction and scale up techniques involved in the development of sustained release dosage forms and delayed release dosage forms.4. Stabilization and Solubilization techniques / Bio equivalent strategies for achieving desired Pharmacokinetic and biodistribution response in new dosage form design, product development and research.5. Preclinical studies such as pharmacokinetics, biodistribution, localization and toxicity in various animal models for developed parenteral and oral dosage forms.6. Helped 3-4 postgradute MS.Pharma (Pharmaceutics) trainee students for designing projects and research.



CSIR-Indian Institute of Chemical Biology

• CSIR-JRF

  • Jun 2009 - Mar 2010

  Synthesis and characterization of DPP-IV inhibitors (heterocyclic compounds). Synthesis and characterization of DPP-IV inhibitors (heterocyclic compounds).